Kovack Advisors’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
Kovack Advisors's IMRX Position: Q3 2026 in Review
Kovack Advisors opened a new position in Immuneering (IMRX) in Q3 2026: 35,700 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #1011 among its holdings.
131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- Kovack Advisors held 35,700 shares of Immuneering worth $144K as of Q3 2026.
- Immuneering was a new Kovack Advisors position in Q3 2026.
- Immuneering made up 0.01% of Kovack Advisors's portfolio in Q3 2026, its #1011 holding.
- 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.